TRDA
Entrada Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:54 PM EST
5.04USD+1.613%(+0.08)815,429
After-hoursNov 18, 2026 4:00:30 PM EST
5.03USD-0.198%(-0.01)
Loading…
Loading…
197.12M
Healthcare
Biotechnology
HQ
Boston, MA, USA
130
Previous Close
$4.96
Beta
1.48
52-Week High
$16.45 2026-05-06
52-Week Low
$4.11 2026-10-14
SMA 50
$5.46
SMA 200
$8.36
Avg. Vol 10D
609,033
Avg. Vol 30D
488,575
Avg. Vol 90D
401,342
Relative Vol
1.67
39.15M
23.12M
59.05%
2,807,309
12.38%
6.88
60%/40%
31.95%
19.20%
0.7300%
850,000
1,031
16,673
47,862
4.0M
-161.4M
-3.84
-136.3M
-4,303.82
-59.88
Nov 18, 2026
Nov 9, 2026
Entrada Therapeutics at Guggenheim: four data readouts loom ·
Investing.com
Nov 5, 2026
Entrada Therapeutics Reports Third Quarter 2026 Financial Results ·
GlobeNewswire Inc.
TRDA Profile
entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.
TRDA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 5.17 | 2026-11-12 | -2.61% | 1.128 |
| 1M | 4.82 | 2026-10-19 | +4.46% | 1.263 |
| 3M | 7.78 | 2026-08-19 | -35.28% | 1.421 |
| 6M | 5.65 | 2026-05-19 | -10.88% | 1.321 |
| 1Y | 8.73 | 2025-11-19 | -42.33% | 1.477 |
| 2Y | 17.77 | 2024-11-19 | -71.67% | — |
| 5Y | 32.79 | 2021-11-19 | -84.64% | 1.095 |
TRDA Stock Summary
Entrada Therapeutics, Inc. Common Stock (NASDAQ:TRDA) stock price today is $5.04, and today's volume is 815,429. TRDA is up 1.512% today. The 30 day average volume is 488,575. TRDA market cap is $197.12M with 39.15M shares outstanding.